Teenage acne and cancer risk in US women: A prospective cohort study

Cancer

Volumn 121, Issue 10, 2015, Pages 1681-1687

  Zhang, Mingfeng ^a   Qureshi, Abrar A ^b   Fortner, Renée T ^a   Hankinson, Susan E ^a,c   Wei, Qingyi ^d   Wang, Li E ^e   Eliassen, A Heather ^a,f   Willett, Walter C ^a,f   Hunter, David J ^a,f   Han, Jiali ^g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d DUKE CANCER INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g INDIANA UNIVERSITY   (United States)

Author keywords

acne; androgen; cancer; melanoma; mole; telomere length

Indexed keywords

ACNE; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; NEVUS; NONHODGKIN LYMPHOMA; NURSE; OVARY CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; THYROID CANCER; UNITED STATES; WOMEN'S HEALTH; ACNE VULGARIS; ADOLESCENT; AGED; BLOOD; BREAST NEOPLASMS; CASE CONTROL STUDY; GENITAL NEOPLASMS, FEMALE; INCIDENCE; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; ODDS RATIO; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RISK FACTOR; SKIN NEOPLASMS; THYROID NEOPLASMS; YOUNG ADULT;

BIOLOGICAL MARKER; TESTOSTERONE;

ACNE VULGARIS; ADOLESCENT; ADULT; AGED; BIOMARKERS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MELANOMA; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; SURVEYS AND QUESTIONNAIRES; TESTOSTERONE; THYROID NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 84929050718     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29216     Document Type: Article

References (45)

1. James WD,. Clinical practice. Acne. N Engl J Med. 2005; 352: 1463-1472.
2. Lolis MS,. Bowe WP, Shalita AR. Acne and systemic disease. Med Clin North Am. 2009; 93: 1161-1181.
3. Folkerd EJ, Dowsett M,. Influence of sex hormones on cancer progression. J Clin Oncol. 2010; 28: 4038-4044.
4. Henderson BE, Feigelson HS,. Hormonal carcinogenesis. Carcinogenesis. 2000; 21: 427-433.
5. Cerhan JR, Vachon CM, Habermann TM, et al. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2002; 11: 1466-1471.
6. Li AJ, Karlan BY,. Androgens and epithelial ovarian cancer: What's the connection? Cancer Biol Ther. 2008; 7: 1712-1716.
7. Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P,. Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann N Y Acad Sci. 2001; 943: 296-315.
8. Lin JH, Giovannucci E,. Sex hormones and colorectal cancer: what have we learned so far? J Natl Cancer Inst. 2010; 102: 1746-1747.
9. Rampen FH, Mulder JH,. Malignant melanoma: an androgen-dependent tumour? Lancet. 1980; 1: 562-564.
10. Sutcliffe S, Giovannucci E, Isaacs WB, Willett WC, Platz EA,. Acne and risk of prostate cancer. Int J Cancer. 2007; 121: 2688-2692.
11. Viladiu P, Izquierdo A, de Sanjose S, Bosch FX,. A breast cancer case-control study in Girona, Spain. Endocrine, familial and lifestyle factors. Eur J Cancer Prev. 1996; 5: 329-335.
12. Baron JA, Weiderpass E, Newcomb PA, et al. Metabolic disorders and breast cancer risk (United States). Cancer Causes Control. 2001; 12: 875-880.
13. Lerner MR, Lerner AB,. Relationship between carcinoma of the breast and acne. Cancer. 1953; 6: 870-872.
14. Moseson M, Koenig KL, Shore RE, Pasternack BS,. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol. 1993; 22: 1000-1009.
15. Bertone-Johnson ER, Hankinson SE, Johnson SR, Manson JE,. Timing of alcohol use and the incidence of premenstrual syndrome and probable premenstrual dysphoric disorder. J Womens Health (Larchmt). 2009; 18: 1945-1953.
16. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1886; 123: 894-900.
17. Amos CI, Wang LE, Lee JE, et al. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet. 2011; 20: 5012-5023.
18. Eliassen AH, Missmer SA, Tworoger SS, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst. 2006; 98: 1406-1415.
19. Tworoger SS, Missmer SA, Eliassen AH, et al. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev. 2006; 15: 967-971.
20. Sodergard R, Backstrom T, Shanbhag V, Carstensen H,. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982; 16: 801-810.
21. Christensen E,. Multivariate survival analysis using Cox's regression model. Hepatology. 1987; 7: 1346-1358.
22. Domínguez-Almendros S, Benítez-Parejo N, Gonzalez-Ramirez AR,. Logistic regression models. Allergol Immunopathol. 2011; 39: 295-305.
23. Nelder JA, Wedderburn RWM,. Generalized linear models. J R Stat Soc Ser A Stat Soc. 1972; 135: 370-384.
24. Cleary MP, Maihle NJ,. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med. 1997; 216: 28-43.
25. Schiavone FE, Rietschel RL, Sgoutas D, Harris R,. Elevated free testosterone levels in women with acne. Arch Dermatol. 1983; 119: 799-802.
26. Lucky AW, McGuire J, Rosenfield RL, Lucky PA, Rich BH,. Plasma androgens in women with acne vulgaris. J InvestDermatol. 1983; 81: 70-74.
27. Simon SR, Ershler WB,. Hormonal influences on growth of B16 murine melanoma. J Natl Cancer Inst. 1985; 741085-1088.
28. Allil PA, Visconti MA, Castrucci AM, Isoldi MC,. Photoperiod and testosterone modulate growth and melanogenesis of s91 murine melanoma. Med Chem. 2008; 4: 100-105.
29. Beral V, Evans S, Shaw H, Milton G,. Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol. 1983: 109: 165-172.
30. Cartwright RA, Hughes BR, Cunliffe WJ,. Malignant melanoma, benzoyl peroxide and acne: a pilot epidemiological case-control investigation. Br J Dermatol. 1988; 118: 239-242.
31. Holly EA, Cress RD, Ahn DK,. Cutaneous melanoma in women. III. Reproductive factors and oral contraceptive use. Am J Epidemiol. 1995; 141: 943-950.
32. Kim SH, Richardson M, Chinnakannu K, et al. Androgen receptor interacts with telomeric proteins in prostate cancer cells. J Biol Chem. 2010; 285: 10472-10476.
33. Bastian BC,. The longer your telomeres, the larger your nevus? Am J Dermatopathol. 2003; 25: 83-84.
34. Nan H, Du M, De Vivo I, et al. Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res. 2011; 71: 6758-6763.
35. Mancuso M, Gallo D, Leonardi S, et al. Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer. Carcinogenesis. 2009; 30: 340-347.
36. Eliassen AH, Hankinson SE,. Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol. 2008: 630: 148-165.
37. Zhang M, Zhang X, Qureshi AA, Eliassen AH, Hankinson SE, Han J,. Association between cutaneous nevi and breast cancer in the Nurses' Health Study: a prospective cohort study. PLoS Med, 2014; 11: e1001659.
38. Yang H, Chen CM, Yan P,. The androgen receptor gene is preferentially hypermethylated in follicular non-Hodgkin's lymphomas. Clin Cancer Res. 2003; 9: 4034-4042.
39. Dimitrakakis C, Bondy C,. Androgens and the breast. Breast Cancer Res. 2009; 11: 212.
40. O'Rahilly R, Muller F,. Human Embryology and Teratology. New York: Wiley-Liss; 1992.
41. Cheng CE, Irwin B, Mauriello D, Liang L, Pappert A, Kimball AB,. Self-reported acne severity, treatment, and belief patterns across multiple racial and ethnic groups in adolescent students. Pediatr Dermatol. 2010; 27: 446-452.
42. Buettner PG, Garbe C,. Agreement between self-assessment of melanocytic nevi by patients and dermatologic examination. Am J Epidemiol. 2000; 151: 72-77.
43. Gallus S, Naldi L, Carli P, La Vecchia C, and Italian Group for Epidemiologic Research in, Dermatology. Nevus count on specific anatomic sites as a predictor of total body count: a survey of 3,406 children from Italy. Am J Epidemiol. 2007; 166: 472-478.
44. Cho E, Rosner BA, Feskanich D, Colditz GA,. Risk factors and individual probabilities of melanoma for whites. J Clin Oncol. 2005; 23: 2669-2675.
45. Nan H, Xu M, Zhang J, et al. (2011). Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. Hum Mol Genet. 2011; 20: 2673-2679.